British Research and Star Wars

The morale of the British scientific community is at its lowest level ever, largely because of the low level of research funds. The total British government expenditure on R&D in 1987 is estimated to be 4.6 billion pounds ($6.5 billion), of which 52 percent is earmarked for military R&D and 21 percent for other government departments. Only 1.2 billion pounds ($1.7 billion) is left for nongovernmental researchers. Britons spend 12 times more on alcohol than their government allocates for nongover

Written byFrank Barnaby
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Small wonder that some scientists are eager to grasp the SDI nettle. When former Defence Minister Michael Heseltine signed the Memorandum of Understanding in December 1985 .that marked Britain's entry into the Star Wars sweepstakes, he prophesied that $1.5 billion of SDI business would come Britain's way. For many, the Heseltine promise seemed like manna from heaven. Such an injection of funds could, it seemed, save many research groups from disbanding and a lot of scientists from unemployment.

Today it is clear that very little SDI money has come to Britain (only about $30 million so far) and that very little can be expected. It is clear, too, that SDI has done nothing to rekindle British research. That realization has helped fuel the debate over British participation in the SDI program.

At the time the Memorandum was signed, British participation was unpopular. Even some Cabinet Ministers, including Foreign Minister Geoffrey ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies